pbm glp-1 news drug coverage for obesity making inroads with large employers: Mercer GLP-1s driving healthcare cost hikes,
Description
Pausing tirzepatide is sometimes medically necessary, but interrupting therapy carries real risks of rapid weight regain and metabolic changes
1 GLP-1
Specifically, this includes muscle loss, decreased muscle strength, and damage to the joints
What happened
Scientists have now created long-lasting GLP-1 drugs that can be used to treat type 2 diabetes, obesity, and a range of other conditions
Tuesday, May 5th 7:30 PM EST | 4:30 PM PST Cant attend live
